SAUTER ANDREW AUGUST 4

4 · AVIGEN INC \DE · Filed Dec 22, 2009

Insider Transaction Report

Form 4

Period: 2009-12-18

AVIGEN INC \DEavgn

SAUTER ANDREW AUGUST

CEO, President and CFO

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−13,333→ 0 total
Exercise: $14.63Exp: 2011-03-09→ Common Stock $0.001 par value (13,333 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−7,500→ 0 total
Exercise: $8.53Exp: 2012-07-02→ Common Stock $0.001 par value (7,500 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−13,000→ 0 total
Exercise: $3.53Exp: 2013-07-11→ Common Stock $0.001 par value (13,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−20,000→ 0 total
Exercise: $3.13Exp: 2014-08-10→ Common Stock $0.001 par value (20,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−5,000→ 0 total
Exercise: $29.00Exp: 2010-05-19→ Common Stock $0.001 par value (5,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−15,000→ 0 total
Exercise: $3.25Exp: 2015-01-03→ Common Stock $0.001 par value (15,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−50,000→ 0 total
Exercise: $3.63Exp: 2016-01-18→ Common Stock $0.001 par value (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−65,000→ 0 total
Exercise: $5.50Exp: 2017-01-03→ Common Stock $0.001 par value (65,000 underlying)
Disposition to Issuer
Common Stock $0.001 par value
2009-12-18−4,125→ 0 total
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−11,000→ 0 total
Exercise: $3.45Exp: 2015-07-12→ Common Stock $0.001 par value (11,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−50,000→ 0 total
Exercise: $5.06Exp: 2016-02-22→ Common Stock $0.001 par value (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−81,845→ 0 total
Exercise: $4.42Exp: 2017-12-05→ Common Stock $0.001 par value (81,845 underlying)

Footnotes (12)

[F1]Disposed of pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc. and Absolute Merger, Inc. in exchange for (a) an amount estimated at $1.23 per share in either cash or secured convertible notes issued by MediciNova, Inc. at the election of the reporting person and (b) one contingent payment right per share which provides for additional potential cash payments, as provided in the merger agreement.
[F10]This option, which provided for vesting of 4,167 shares on May 22, 2006, 2007, and 2008, August 22, 2006, 2007, and 2008, and February 22, 2007, 2008, and 2009, respectively, 4,165 shares on November 22, 2006, and 4,166 shares on November 22, 2007 and 2008, respectively, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F11]This option, which provided for vesting in twelve equal quarterly installments beginning January 3, 2007, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F12]This option, which provided for vesting in twelve equal quarterly installments beginning December 5, 2007, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F2]This option, which provided for vesting in sixteen equal quarterly installments beginning July 1, 2000, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F3]This option, which provided for vesting in sixteen equal quarterly installments beginning July 1, 2001, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F4]This option, which provided for vesting in sixteen equal quarterly installments beginning July 2, 2002, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F5]This option, which provided for vesting in sixteen equal quarterly installments beginning July 1, 2003, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F6]This option, which provided for vesting in sixteen equal quarterly installments beginning July 1, 2004, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F7]This option, which provided for vesting in sixteen equal quarterly installments beginning January 1, 2005, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F8]This option, which provided for vesting in sixteen equal quarterly installments beginning July 1, 2005, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
[F9]This option, which provided for vesting in sixteen equal quarterly installments beginning January 10, 2006, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT